These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29716897)

  • 1. Prospective Randomized Biomarker Study of Metformin and Lifestyle Intervention for Prevention in Obese Women at Increased Risk for Endometrial Cancer.
    Yates MS; Coletta AM; Zhang Q; Schmandt RE; Medepalli M; Nebgen D; Soletsky B; Milbourne A; Levy E; Fellman B; Urbauer D; Yuan Y; Broaddus RR; Basen-Engquist K; Lu K
    Cancer Prev Res (Phila); 2018 Aug; 11(8):477-490. PubMed ID: 29716897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Physical Activity and Weight Loss on Fat Mass, Glucose Metabolism, and Inflammation in Older African Americans with Osteoarthritis.
    McLeod A; Schiffer L; Castellanos K; DeMott A; Olender S; Fitzgibbon M; Hughes S; Fantuzzi G; Tussing-Humphreys L
    Nutrients; 2020 Oct; 12(11):. PubMed ID: 33126555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.
    Hoeger KM; Kochman L; Wixom N; Craig K; Miller RK; Guzick DS
    Fertil Steril; 2004 Aug; 82(2):421-9. PubMed ID: 15302293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for weight reduction in obesity to improve survival in women with endometrial cancer.
    Kitson S; Ryan N; MacKintosh ML; Edmondson R; Duffy JM; Crosbie EJ
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012513. PubMed ID: 29388687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of a low-calorie diet or an isocaloric diet combined with metformin on sex hormones In obese women of child-bearing age.
    Swora-Cwynar E; Kujawska-Łuczak M; Suliburska J; Reguła J; Kargulewicz A; Kręgielska-Narożna M; Marcinkowska E; Kanikowska A; Bielas M; Grzymisławski M; Bogdański P
    Acta Sci Pol Technol Aliment; 2016; 15(2):213-220. PubMed ID: 28071011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Dose, Diazoxide-Mediated Insulin Suppression Boosts Weight Loss Induced by Lifestyle Intervention.
    Loves S; van Groningen L; Filius M; Mekking M; Brandon T; Tack CJ; Hermus A; de Boer H
    J Clin Endocrinol Metab; 2018 Nov; 103(11):4014-4022. PubMed ID: 30202851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions for weight reduction in obesity to improve survival in women with endometrial cancer.
    Agnew H; Kitson S; Crosbie EJ
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD012513. PubMed ID: 36971688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological and non-pharmacological strategies for obese women with subfertility.
    Taghavi SA; van Wely M; Jahanfar S; Bazarganipour F
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012650. PubMed ID: 33765343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PROgesterone Therapy for Endometrial Cancer Prevention in Obese Women (PROTEC) Trial: A Feasibility Study.
    Derbyshire AE; Allen JL; Gittins M; Lakhiani B; Bolton J; Shaw J; Pemberton PW; Needham M; MacKintosh ML; Edmondson RJ; Kitchener HC; Crosbie EJ
    Cancer Prev Res (Phila); 2021 Feb; 14(2):263-274. PubMed ID: 32998940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of a lifestyle intervention on body weight and serum biomarkers in breast cancer survivors with overweight and obesity.
    Campbell KL; Van Patten CL; Neil SE; Kirkham AA; Gotay CC; Gelmon KA; McKenzie DC
    J Acad Nutr Diet; 2012 Apr; 112(4):559-67. PubMed ID: 22709706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recruitment strategies, design, and participant characteristics in a trial of weight-loss and metformin in breast cancer survivors.
    Patterson RE; Marinac CR; Natarajan L; Hartman SJ; Cadmus-Bertram L; Flatt SW; Li H; Parker B; Oratowski-Coleman J; Villaseñor A; Godbole S; Kerr J
    Contemp Clin Trials; 2016 Mar; 47():64-71. PubMed ID: 26706665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial biomarkers in premenopausal women with obesity: an at-risk cohort.
    Dottino JA; Zhang Q; Loose DS; Fellman B; Melendez BD; Borthwick MS; McKenzie LJ; Yuan Y; Yang RK; Broaddus RR; Lu KH; Soliman PT; Yates MS
    Am J Obstet Gynecol; 2021 Mar; 224(3):278.e1-278.e14. PubMed ID: 32835719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol.
    Martinez JA; Chalasani P; Thomson CA; Roe D; Altbach M; Galons JP; Stopeck A; Thompson PA; Villa-Guillen DE; Chow HH
    BMC Cancer; 2016 Jul; 16():500. PubMed ID: 27430256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemopreventive effects of metformin on obesity-associated endometrial proliferation.
    Zhang Q; Celestino J; Schmandt R; McCampbell AS; Urbauer DL; Meyer LA; Burzawa JK; Huang M; Yates MS; Iglesias D; Broaddus RR; Lu KH
    Am J Obstet Gynecol; 2013 Jul; 209(1):24.e1-24.e12. PubMed ID: 23500454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes.
    Santilli F; Simeone PG; Guagnano MT; Leo M; Maccarone MT; Di Castelnuovo A; Sborgia C; Bonadonna RC; Angelucci E; Federico V; Cianfarani S; Manzoli L; Davì G; Tartaro A; Consoli A
    Diabetes Care; 2017 Nov; 40(11):1556-1564. PubMed ID: 28912305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of novel technology-based weight loss interventions for obese women with endometrial hyperplasia and cancer.
    Haggerty AF; Huepenbecker S; Sarwer DB; Spitzer J; Raggio G; Chu CS; Ko E; Allison KC
    Gynecol Oncol; 2016 Feb; 140(2):239-44. PubMed ID: 26644265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiposity and Endometrial Cancer Risk in Postmenopausal Women: A Sequential Causal Mediation Analysis.
    Dashti SG; English DR; Simpson JA; Karahalios A; Moreno-Betancur M; Biessy C; Rinaldi S; Ferrari P; Tjønneland A; Halkjær J; Dahm CC; Vistisen HT; Menegaux F; Perduca V; Severi G; Aleksandrova K; Schulze MB; Masala G; Sieri S; Tumino R; Macciotta A; Panico S; Hiensch AE; May AM; Quirós JR; Agudo A; Sánchez MJ; Amiano P; Colorado-Yohar S; Ardanaz E; Allen NE; Weiderpass E; Fortner RT; Christakoudi S; Tsilidis KK; Riboli E; Kaaks R; Gunter MJ; Viallon V; Dossus L
    Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):104-113. PubMed ID: 33008875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses.
    Harborne LR; Sattar N; Norman JE; Fleming R
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4593-8. PubMed ID: 15886247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
    Ujvari D; Hulchiy M; Calaby A; Nybacka Å; Byström B; Hirschberg AL
    Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of obesity and bariatric surgery on circulating and tissue biomarkers of endometrial cancer risk.
    MacKintosh ML; Derbyshire AE; McVey RJ; Bolton J; Nickkho-Amiry M; Higgins CL; Kamieniorz M; Pemberton PW; Kirmani BH; Ahmed B; Syed AA; Ammori BJ; Renehan AG; Kitchener HC; Crosbie EJ
    Int J Cancer; 2019 Feb; 144(3):641-650. PubMed ID: 30289975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.